• All Topics
  • Health Technology Assessment (HTA)
  • Antimicrobial Resistance (AMR)
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real-World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme
  • IRA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

  • Health Technology Assessment…
  • Israel

NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?

andrew-butler-aUu8tZFNgfM-unsplash
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Gene therapies

Are Recommendations for HTA of Gene Therapies Being Achieved?

cover 3
Read more
  • Chronic Diseases
  • Value, Affordability, and…
  • Dermatology

The Burden of Hidradenitis Suppurativa on Patients, the NHS and Society

jakob-braun-HfOOKAPsE28-unsplash
Read more
  • Digital Health
  • Economics of Innovation
  • Mental Health

Dementia in the UK: Estimating the Potential Future Impact and Return on Research Investment

image option 1
Read more
  • Precision Medicine
  • Economics of Innovation

The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe

NGS report_AdobeStock_406823942_portrait
Read more
  • Antimicrobial Resistance (AMR)
  • Economics of Innovation

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Roche AMR diangostics_national-cancer-institute-2fyeLhUeYpg-unsplash_portrait
Read more
  • Health Technology Assessment…
  • Value, Affordability, and…
  • Pricing and Reimbursement

Real-World Evidence: Current Best Practice for Reimbursement Decision-Making

RWE_clay-banks-b5S4FrJb7yQ-unsplash_portrait
Read more
  • Value-Based Pricing
  • Economics of Innovation
  • Pricing and Reimbursement

Delivering the Triple Win: A Value-Based Approach to Pricing

Triple_Win_AdobeStock_249059909_portrait_v2
Read more
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real-World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • IRA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 5th June 2017

OHE at the PROMs Research Conference 2017

OHE at the PROMs Research Conference 2017 (Advances in Patient Reported Outcomes Research) Following the success of last year’s inaugural conference in Sheffield (see here for a summary of OHE’s contributions), the second annual UK & Ireland PROMs Conference will…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

OHE at the PROMs Research Conference 2017 (Advances in Patient Reported Outcomes Research)

Following the success of last year’s inaugural conference in Sheffield (see here for a summary of OHE’s contributions), the second annual UK & Ireland PROMs Conference will be held at St Anne’s College, Oxford on 8th June 2017. This one-day conference will include a mixture of plenary sessions, oral presentations and posters by PROMs (patient reported outcome measures) researchers from across the UK and Ireland.

The event will bring together leading experts and early career researchers to engage with the latest advances in the field of PROMs research and implementation. Several members of the OHE team will be attending and contributing to the conference.

Bernarda Zamora will be presenting findings from an OHE research project which has developed new methods for analysing the distribution of EQ-5D observations. She will provide information about novel ways of describing the distribution of EQ-5D states observed in any given data set – the Health State Density Index and Health State Density Curve, and estimated Power Law functions. This research, funded by the EuroQol Research Foundation, is being undertaken in collaboration with OHE’s Yan Feng, Mike Herdman and Nancy Devlin, OHE Senior Visiting Fellow David Parkin, and Andrew Bateman of the Cambridgeshire Community Services NHS Trust. The methods can be applied to any patient reported outcomes data.

Koonal Shah will be presenting the methods and preliminary findings of two research studies currently in progress intended to generate stated preference data to support the development of a value set for the EQ-5D-Y, the ‘youth’ version of the EQ-5D. The first study seeks to obtain latent scale value using a discrete choice experiment. The second study explores alternative ways of anchoring those values at zero, as required for the estimation of QALYs. OHE’s research on EQ-5D-Y valuation is being undertaken by Koonal and Nancy Devlin in collaboration with Juan-Manuel Ramos-Goni of the EuroQol Office, Oliver Rivero-Arias of the University of Oxford, Simone Kreimeier of the University of Bielefeld, and Ben van Hout of the University of Sheffield.

Koonal is also co-author of a study on using patient valuations of EQ-5D health states to improve hospital performance comparisons, to be presented by Thomas Patton of the Centre for Health Economics, University of York.

Finally, Patricia Cubi-Molla will be presenting a poster entitled: Re-thinking the concept of experience-based values: setting the right framework to estimate the effect of experience on health. The poster will draw on preliminary findings from a research study funded by the EuroQol Research Foundation. 

For further information about the conference, click here.

For further information about OHE’s involvement in the conference, contact the OHE authors via our Meet the Team page. For general enquiries about OHE’s research on patient reported outcomes, contact Nancy Devlin.

  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes
  • Spotlight on OHE

Related News

  • News
  • November 2021

Opportunity Cost in Health Care: a Favourite Research Topic for OHE

Read more
  • News
  • May 2020

OHE Awarded Independent Research Organisation (IRO) Status by UKRI

Read more
  • News
  • February 2019

OHE Response to Public Consultation on NICE Principles

Read more
  • News
  • December 2018

OHE Achievements in 2018

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for OHE Insights, Events & News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!